Drug Interactions between Brukinsa and Vitamin B12
This report displays the potential drug interactions for the following 2 drugs:
- Brukinsa (zanubrutinib)
- Vitamin B12 (cyanocobalamin)
Interactions between your drugs
No interactions were found between Brukinsa and Vitamin B12. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Brukinsa
A total of 472 drugs are known to interact with Brukinsa.
- Brukinsa is in the drug class BTK inhibitors.
- Brukinsa is used to treat the following conditions:
Vitamin B12
A total of 15 drugs are known to interact with Vitamin B12.
- Vitamin b12 is in the drug class vitamins.
- Vitamin b12 is used to treat the following conditions:
Drug and food interactions
zanubrutinib food
Applies to: Brukinsa (zanubrutinib)
Grapefruit juice and Seville orange juice can increase the blood levels of zanubrutinib. This may increase side effects such as rash, diarrhea, constipation, cough, hemorrhage, development of other cancers, abnormal heart rhythm, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. You should avoid the consumption of Seville oranges, Seville orange juice, grapefruit and grapefruit juice during treatment with zanubrutinib. Be sure to take the medication at approximately the same time(s) everyday to maintain consistent blood levels and effects. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.